334.5 EUR
5
1.47%
Last update Dec 16, 4:00 PM CET
Market closed
Day range
329.70001
334.5
Previous close
339.5
Open
329.89999
Access this stock data via API
Subscribe
Alnylam Pharmaceuticals Inc.
334.50
5
1.47%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 1.9B 1.8B 1.0B 844.3M
Cost of revenue 275.6M 310.4M 168.8M 140.1M
Gross profit 1.6B 1.5B 868.6M 704.1M
Operating expense
Research & development 959.8M 1.0B 883.0M 792.2M
Selling general and admin 831.4M 795.6M 770.7M 620.6M
Other operating expenses
Operating income -150.8M -282.2M -785.1M -708.7M
Non operating interest income
Income 104.0M 95.6M 24.8M 1.6M
Expense 120.9M 121.2M 156.0M 143.0M
Other income expense -153.9M -125.7M -210.8M -2.1M
Pretax income -321.6M -433.5M -1.1B -852.1M
Tax provision -84.6M 6.7M 4.2M 680K
Net income -237.1M -440.2M -1.1B -852.8M
Basic EPS -2.2 -3.5 -9.3 -7.2
Diluted EPS -2.2 -3.5 -9.3 -7.2
Basic average shares 108.8M 130.0M 126.6M 123.3M
Diluted average shares 108.8M 130.0M 126.6M 123.3M
EBITDA -4.3M -107.3M -680.9M -636.7M
Net income from continuing op. -237.1M -440.2M -1.1B -852.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 1 hour 42 minutes

06:17
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).